The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
*roughly 28 million options. (Sorry, added it up incorrectly š)
Help me out, please? What are these options? Is it that the team have been given roughly 35 million shares (for free) which they can sell if the price gets to 17.9p?
If I/we get a message from H&L shortly after the week commencing 13th November, that would be encouraging. I donāt think they would be sending messages unless something was verified.
Pharma will have been looking at the data all year but the patent opposition was probably preventing them from signing a deal. Now that is cleared up, I imagine something will be signed quite quickly. They will have been preparing all year, now is the green light to get it finished. Hopefully.
What are the āchanges to the companies websiteā? Just that there is a blurry American flag? Is that it?!
I just donāt understand how we have FDA approval for ground breaking tech and yet the share price is drifting lower and lower. Surely sales should be rolling in. What happened?
For no logical reason, after this update, I feel strangely optimistic. Iāve gone from hopeful but with healthy scepticism to feeling it might actually be true. Anybody else?
Oh, yeah, I get it. I just meant it was an AIM share once upon a time and AIM is the Wild West of investing.
Thatās why I asked my question about dilution. The āas of todayās dateā implies to me the expectation of more shares being sold afterwards.
Itās all in the hands of the Risky AIM Share Gods now.
Hereās hoping I get back a tenner š
Ah, I see š¤¦āāļø Thank you.
Since the November update stating how many shares were in issue, have people been saying they have had the opportunity to buy more shares? Iām trying to work out, on the slightest off chance this is real, whether to expect dilution in the distribution.
I get that all this is unlikely to ever come to fruitionā¦but thereās also a part of me that canāt come to any logical conclusion why Amit is prolonging this with endless updates if there isnāt something in it. Iām truly flummoxed.
Iāve not really been keeping up with the chat here. Have people explained why they think heās extending it, if itās all fictional?
If this comes good Iām not going to refuse the proceeds because the updates werenāt in perfect English.
That made me lol! š¤£
Message to copy and paste if it helps. Sent to Hargreaves Lansdown with confirmed reply.
Please vote on my behalf in the 88 Energy Limited (ASX:88E, AIM:88E, OTC:EEENF) Annual General Meeting (AGM) to be held on Thursday 11 May 2023.
Vote for Resolutions 1 to 5, and against Resolution 6.
Ā£1m inventory is a lot of salt for the āsignificant forthcoming ordersā. I like it. Hopefully the previously mentioned conversations with the Fortune 500 companies are coming to fruition.
I think youāre out by a factor of 10, roughly 500k shares, about Ā£75k. Out of his holding, itās pretty tiny.
A couple of months ago he (?) didnāt know what a double blind trial meant. Now he thinks he knows more than the Professor of Immunology.
Agreed. Iām just trying to counter the nonsense with actual facts, in case anyone reads the nonsense and believes it.
I will grovel at your feet for forgiveness.
What will you say when they release an RNS with a monster pharma deal?